Studies related to Treatment of Myotonic Dystrophy and Creatine

Creatine Monohydrate In Myotonic Dystrophy: A Double-blind, Placebo-controlled Clinical Study

Effect Increase
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 34
Sex Both Genders
Age Range 30-44, 45-64
Body Types Average
Notes for this study:
Individuals with myotonic dystrophy received 10.6 g/day for 10 days followed by 5.3 g/day for 46 days. No effect was noted until the second half of the study (it was a cross-over design), when some of the parameters that worsened in the placebo group improved in the creatine group. The improvement was slight, if statistically significant, which suggest very minor therapeutic benefits.

Full details on all 3 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.